Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Income towards Parent Company: 2022-2023

Historic Income towards Parent Company for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$5.2 million.

  • Mainz Biomed N.V's Income towards Parent Company rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.82% up from last year.
  • Per Mainz Biomed N.V's latest filing, its Income towards Parent Company stood at -$5.2 million for Q4 2023, which was up 17.72% from -$6.3 million recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Income towards Parent Company high stood at -$5.2 million for Q4 2023, and its period low was -$8.3 million during Q2 2023.
  • Moreover, its 2-year median value for Income towards Parent Company was -$6.4 million (2023), whereas its average is -$6.6 million.
  • Over the last 5 years, Mainz Biomed N.V's Income towards Parent Company had its largest YoY gain of 36.70% in 2023, and its largest YoY loss of 18.92% in 2023.
  • Over the past 2 years, Mainz Biomed N.V's Income towards Parent Company (Quarterly) stood at -$8.2 million in 2022, then soared by 36.70% to -$5.2 million in 2023.
  • Its last three reported values are -$5.2 million in Q4 2023, -$6.3 million for Q3 2023, and -$8.3 million during Q2 2023.